Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Maternal Health topic

No spam. Unsubscribe anytime.

Tennessee House approves additional syphilis screenings for pregnancy after debate over mandate and access

2520647 · March 6, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The Tennessee House passed Senate Bill 1283 to add a second syphilis screening late in pregnancy and at delivery. Sponsors said the measure responds to rising congenital syphilis; opponents raised questions about whether the law would mandate testing and how patients without ready access to care would be affected.

The Tennessee House of Representatives on third and final consideration approved Senate Bill 1283, a measure that adds an additional syphilis screening between the 28th and 32nd week of gestation and at the time of delivery, after a floor debate about whether the bill creates a mandatory test and how it would affect patients with limited access to care.

Sponsor Representative Martin, the bill’s floor sponsor, said the measure updates testing frequency to address a rise in congenital syphilis in Tennessee. “This bill updates the frequency of Tennessee testing requirements, and it adds an additional syphilis screening between the 28th and 32nd week of gestation, as well as at the time of delivery,” Martin said on the House floor, citing data that led sponsors to seek later testing during pregnancy.

The bill’s nut graf: supporters said SB 1283 is intended to identify infections acquired later in pregnancy so providers can treat pregnant people and reduce the risk of adverse birth outcomes, while critics pressed for clarity about whether the statute would require tests and what consequences, if any, would follow for patients or providers who do not obtain testing.

Floor debate focused on statutory language and real-world access. Representative Dixie directly questioned whether the bill’s use of “shall” in statutory text creates a mandatory requirement, saying, “So when I’m looking at this bill, it looks like it says shall. And, normally, when it says shall, that seems like that’s a requirement rather than it’s optional.” Martin replied the bill provides guidance to health-care professionals and that individuals retain the ability to refuse testing, stating, “It’s recommended by the health department. But like any treatment, an individual doesn't have to take an aspirin or take penicillin or take anything if they don't want to.”

Chairman Clemens and Representative Hardaway raised access concerns, asking what enforcement or penalties would apply and how the bill would operate in areas with limited maternal-care access. Clemens asked whether there is “a penalty for that woman? Is there a penalty for her health care provider who may have treated her before that?” Martin said he did not understand the bill to create penalties and reiterated the goal of earlier detection and treatment to prevent congenital infection.

Other members framed the bill as a public-health intervention. Representative Hilton Haynes urged support, noting syphilis can cause blindness and other serious outcomes in infants. Representative Towns and Leader Lambeth expressed support, describing the bill as a measure to produce healthier births.

Vote and outcome: The House approved the bill on third reading. The roll-call tally recorded in the transcript was 79 yeas, 12 nays and 1 present/not voting; the presiding officer declared the bill received a constitutional majority and passed on third and final consideration.

What SB 1283 does (as described on the floor): sponsors said the bill changes Tennessee’s testing guidance to require an additional syphilis screening in the late second / early third trimester (described on the floor as between the 28th and 32nd week) and at delivery; floor remarks clarified the screening is performed from blood samples already taken for other prenatal tests. The sponsor characterized the change as guidance that would lead health-care providers to include syphilis testing at those moments in pregnancy so infections acquired later in pregnancy can be detected and treated.

Unresolved implementation details in the debate: lawmakers asked whether testing would be mandatory in practice, whether a person who has a blood draw could refuse the blood being tested for syphilis, and what protections apply where prenatal care access is limited. The sponsor said the bill does not create penalties and does not change a patient’s right to refuse tests; several members requested that those access and enforcement questions be clarified in agency guidance or later rulemaking.

Next steps and context: With passage in the House, the bill will proceed according to the Legislature’s process (the transcript shows the House’s final passage vote; it does not record subsequent actions such as enrollment or the governor’s consideration). Lawmakers cited a multi-year rise in congenital syphilis in Tennessee as the rationale for the change; the bill’s text as discussed focuses on screening timing rather than on new criminal or civil penalties.

Ending: Supporters said the measure aims to give health-care providers and pregnant people actionable information to prevent congenital infections; opponents urged attention to access and statutory language to ensure the change operates as intended in communities with limited prenatal care.